Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 CAD | +2.36% | -8.45% | +46.07% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 160.4 | 70.87 | 50.91 | 72.81 | - |
Enterprise Value (EV) 1 | 160.4 | 70.87 | 50.91 | 72.81 | 72.81 |
P/E ratio | -7.21 x | - | - | - | - |
Yield | - | - | - | - | - |
Capitalization / Revenue | - | 0.31 x | 0.2 x | 0.26 x | 0.22 x |
EV / Revenue | - | 0.31 x | 0.2 x | 0.26 x | 0.22 x |
EV / EBITDA | - | 11.1 x | 2.33 x | 3.02 x | 2.03 x |
EV / FCF | - | -8.36 x | - | 7.21 x | 4.77 x |
FCF Yield | - | -12% | - | 13.9% | 21% |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 57,093 | 57,155 | 57,206 | 57,331 | - |
Reference price 2 | 2.810 | 1.240 | 0.8900 | 1.270 | 1.270 |
Announcement Date | 3/21/22 | 3/29/23 | 3/26/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | 63.31 | - | 226.4 | 259.3 | 279.2 | 323.6 |
EBITDA 1 | - | - | 6.412 | 21.83 | 24.1 | 35.9 |
EBIT 1 | - | - | -7.542 | - | 12.7 | 22 |
Operating Margin | - | - | -3.33% | - | 4.55% | 6.8% |
Earnings before Tax (EBT) | - | - | - | - | - | - |
Net income | -2.073 | -20.61 | - | - | - | - |
Net margin | -3.27% | - | - | - | - | - |
EPS | - | -0.3900 | - | - | - | - |
Free Cash Flow 1 | - | - | -8.473 | - | 10.1 | 15.27 |
FCF margin | - | - | -3.74% | - | 3.62% | 4.72% |
FCF Conversion (EBITDA) | - | - | - | - | 41.93% | 42.53% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/13/21 | 3/21/22 | 3/29/23 | 3/26/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 47.6 | 49.83 | 56.3 | 58.91 | 61.38 | - | 67.4 | 64.26 | 70.28 | 72.48 | 75.53 |
EBITDA 1 | 0.012 | -0.174 | 2.104 | 2.279 | 2.203 | - | 6.391 | 4.481 | 5.6 | 6.6 | 7.4 |
EBIT | - | - | - | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - |
Net income | - | - | -1.37 | - | - | 2.097 | - | - | - | - | - |
Net margin | - | - | -2.43% | - | - | - | - | - | - | - | - |
EPS | - | - | -0.0200 | - | - | 0.0400 | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/21/22 | 5/9/22 | 8/12/22 | 11/8/22 | 3/29/23 | 11/8/23 | 3/26/24 | 5/8/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -8.47 | - | 10.1 | 15.3 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | - | - | 8.41 | - | 5.9 | 6.18 |
Capex / Sales | - | - | 3.71% | - | 2.11% | 1.91% |
Announcement Date | 4/13/21 | 3/21/22 | 3/29/23 | 3/26/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.07% | 53.21M | |
+15.00% | 3.01B | |
+17.18% | 1.73B | |
+1.36% | 492M | |
+45.54% | 186M | |
+1.89% | 104M | |
+1.67% | 98.08M |
- Stock Market
- Equities
- NOVC Stock
- Financials Nova Cannabis Inc.